TY - JOUR
T1 - Burrowing through the heterogeneity
T2 - Review of mouse models of PTCL-NOS
AU - Cutucache, Christine E.
AU - Herek, Tyler A.
N1 - Funding Information:
The authors acknowledge the National Science Foundation GRFP (TH), the University of Nebraska Foundation (CC), and the College of Arts and Sciences at the University of Nebraska at Omaha for funding this work
Publisher Copyright:
© 2016 Cutucache and Herek.
PY - 2016/9/26
Y1 - 2016/9/26
N2 - Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.
AB - Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.
KW - Genetically engineered
KW - Mouse models
KW - Neoplasms
KW - PTCL-NOS
KW - T-cell lymphoma
UR - http://www.scopus.com/inward/record.url?scp=84991826692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991826692&partnerID=8YFLogxK
U2 - 10.3389/fonc.2016.00206
DO - 10.3389/fonc.2016.00206
M3 - Short survey
C2 - 27725924
AN - SCOPUS:84991826692
SN - 2234-943X
VL - 7
JO - Frontiers in Oncology
JF - Frontiers in Oncology
IS - SEP
M1 - 206
ER -